TG Therapeutics, Inc. (TGTX)
NASDAQ: TGTX · Real-Time Price · USD
36.72
-1.23 (-3.24%)
Jun 27, 2025, 4:00 PM - Market closed
TG Therapeutics Market Cap
TG Therapeutics has a market cap or net worth of $5.36 billion as of June 27, 2025. Its market cap has increased by 117.94% in one year.
Market Cap
5.36B
Enterprise Value
5.33B
1-Year Change
117.94%
Ranking
Category
Stock Price
$36.72
Market Cap Chart
Since May 3, 2010, TG Therapeutics's market cap has increased from $9.10M to $5.36B, an increase of 58,747.73%. That is a compound annual growth rate of 52.30%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jun 26, 2025 | 6.02B | 28.58% |
| Dec 31, 2024 | 4.69B | 81.18% |
| Dec 29, 2023 | 2.59B | 50.41% |
| Dec 30, 2022 | 1.72B | -36.69% |
| Dec 31, 2021 | 2.72B | -60.29% |
| Dec 31, 2020 | 6.84B | 518.96% |
| Dec 31, 2019 | 1.11B | 225.13% |
| Dec 31, 2018 | 339.90M | -41.33% |
| Dec 29, 2017 | 579.30M | 127.62% |
| Dec 30, 2016 | 254.50M | -59.38% |
| Dec 31, 2015 | 626.60M | -10.02% |
| Dec 31, 2014 | 696.40M | 433.23% |
| Dec 31, 2013 | 130.60M | 43.20% |
| Dec 31, 2012 | 91.20M | 91,100.00% |
| Dec 30, 2011 | 100.00K | -97.92% |
| Dec 31, 2010 | 4.80M | -47.25% |
View and export this data all the way back to 2010.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 713.81B |
| Johnson & Johnson | 365.75B |
| AbbVie | 329.95B |
| Novo Nordisk | 299.93B |
| UnitedHealth Group | 274.52B |
| Novartis AG | 235.02B |
| Abbott Laboratories | 232.56B |
| AstraZeneca | 215.99B |